Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes

被引:6
作者
Kotturi, SV [1 ]
Jiang, SC [1 ]
Chang, AC [1 ]
Abraham, P [1 ]
Navarro, HA [1 ]
Kuhar, MJ [1 ]
Carroll, FI [1 ]
机构
[1] Res Triangle Inst, Ctr Organ & Med Chem, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/jm0582423
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Synthetic procedures were developed for the synthesis of 2 beta,3 beta- and 2 alpha,3 alpha-diaryltropanes. These compounds are analogues of the 3-aryltropane-2 beta-carboxylic acid methyl ester class of monoamine uptake inhibitors, where the 2 beta-carbomethoxy group has been replaced by an aryl group. The compounds were evaluated for inhibition of radioligand binding at the dopamine, norepinephrine, and serotonin transporters (DAT, NET, and 5-HTT, respectively). The results showed that the replacement of the 2 beta-carbomethoxy group in the 3-aryltropane class with a 2 beta-aryl group led to compounds possessing very similar monoamine transporter binding properties. However, the 2 beta,3 beta-diaryltropanes tended to be more potent at the DAT and more selective for the DAT relative to the NET and 5-HTT. One of the most interesting compounds was 3 beta-(4-methylphenyl)-2 beta-(4-methylphenyl)tropane (3d), which showed an IC50 of 1.23 nM at the DAT with 289- and 185-fold selectivity for the DAT relative to the NET and 5-HTT. The 2 alpha,3 alpha-diaryltropanes were much less potent at all three transporters than 2 beta,3 beta-diaryltropanes.
引用
收藏
页码:7437 / 7444
页数:8
相关论文
共 14 条
[11]   Synthesis and transporter binding properties of (R)-2β,3β- and (R)-2α,3α-diaryltropanes [J].
Jiang, SC ;
Chang, AC ;
Abraham, P ;
Kuhar, MJ ;
Carroll, FI .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) :3689-3692
[12]   Pharmacotherapy of addictions [J].
Kreek, MJ ;
LaForge, KS ;
Butelman, E .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) :710-726
[13]   THE DOPAMINE HYPOTHESIS OF THE REINFORCING PROPERTIES OF COCAINE [J].
KUHAR, MJ ;
RITZ, MC ;
BOJA, JW .
TRENDS IN NEUROSCIENCES, 1991, 14 (07) :299-302
[14]   Novel pharmacotherapies for cocaine abuse 1997-2000 [J].
Newman, AH .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (07) :1095-1122